AURKA forms a complex with N-MYC, protecting it from FBW7-mediated degradation, and inhibitors of AURKA disrupt the MYC–AURKA complex, promoting N-MYC degradation and tumor regression [158]. This evidence concerns the gene MYCN and neoplasm.